C. Ben Huber

C. Ben Huber

Shareholder

Ben Huber is a transactional attorney who counsels a broad range of domestic and foreign clients, including startups, closely held businesses, middle-market companies, family offices, funds and other institutional investors in various corporate matters. Ben's practice focuses on mergers and acquisitions, business restructuring, capital markets transactions, including debt financing and private placements, and fund formation. As counsel to several high tech, bio tech and software businesses, Ben also has experience with both inbound and outbound technology licensing.

Concentrations

  • Purchase and sale of companies and business divisions
  • Restructuring and reorganization of company assets, liabilities and ownership
  • Capital markets transactions, including debt financing and private placements
  • Formation of real estate and other investment funds 
  • Inbound and outbound technology licensing
  • Manufacturing, supply and distribution relationships
  • Corporate governance
Visualizza di più+

Competenze

Esperienze Professionali

  • Represented Adesis, Inc., a contract research organization (CRO) for chemical compounds, in its acquisition by Universal Display Corporation, Inc., a leading developer and manufacturer of organic light emitting diodes (OLED) technologies and materials, in a reverse triangular merger for cash and the issuance of certain shares of restricted stock in UDC to Adesis’ management.
  • Represented Ranch-Way Feeds, the largest manufacturer and distributor of animal feed in the Rocky Mountain region, in the sale of substantially all of its assets, including various historic real property, plants and equipment, to Ridley USA.
  • Represented a family office in the purchase of 13 separate automotive franchises from a dealership group based in Minnesota.
  • Represented the US subsidiary of a public Taiwanese company in the acquisition of a leading golf club shaft distribution business based in Colorado.
  • Represented a commercial fire sprinkler installation company (with a unionized workforce) in the sale of its assets to a fundless sponsor.
  • Represented a group of individual investors in the acquisition of all of the stock of a closely-held business that manufactures and distributes vending machines globally through its US and Mexican facilities.
  • Represented a private real estate investment company in the sale of a controlling equity stake to a public holding company (NYSE) focused on the financial services sector as an asset management vehicle for its insurance platform, including the subsequent repurchase of such stake and sale of all of the equity of such company.
  • Represented a private Dutch holding company in the sale of substantially all of its commercial spaceflight marketing, ticketing and training businesses to a private U.S. aerospace company developing reusable suborbital and orbital launch vehicles (RLVs), rocket engines and rocket propulsion systems (with a concurrent investment in the acquirer).
  • Represented a small investor group in the acquisition of substantially all of the assets of four affiliated businesses involved in the manufacture, distribution and recycling of sustainable heat transfer fluids (e.g., propylene, glycol and glycerin) and the follow-on acquisition of two additional small anti-freeze businesses.
  • Represented a primary care physician practice group that focuses on making house calls to nursing homes in the sale of the founders’ equity to a publicly-traded Fortune 500 healthcare company.
  • Represented a neurology practice (4 locations) and MRI center in the sale of substantially all of their assets, including the transfer of real estate and several equipment leases.
  • Represented the executive management team of Water Pik, Inc., a global oral healthcare products company, in its sale from one private equity firm (EG Capital Group, LLC) to another (MidOcean Partners).
  • Represented Attila Resources Limited, an Australian public company (ASX), in its acquisition from Walter Minerals, Inc., a U.S. public company (NYSE), of a coal mining operation in Alabama through the purchase of 100% of the membership interests of the Walter Minerals subsidiary that owned and operated the mining business.
  • Represented a private auto dealership group in the leveraged acquisition of numerous dealerships in Colorado, Tennessee and New England. 
  • Represented a public Australian engineering firm (ASX) in its divestiture of certain non-core U.S. assets.
  • Represented a mid-stream oil and gas holding company in the auction and sale of a natural gas storage facility with 12 billion cubic feet of capacity through a reverse triangular merger structure. 
  • Represented a private medical device company engaged in the commercialization of various biologics products that optimize growth factors in human allografts in a reverse "going public" transaction and concurrent PIPE. 
  • Represented a major producer of diamond wire in the sale of substantially all of its assets, including proprietary cutting technology, to a public Swiss saw manufacturer for cash and shares of stock registered on the SIX Swiss Exchange. 
  • Represented a group of executives in connection with its management buy-out of a Canadian company's U.S. assets related to a hard rock mining technique for the extraction of oil from semi-depleted fields. 
  • Represented a private Canadian construction software firm in connection with its acquisition of substantially all of the assets of a U.S. software company. 
  • Represented a private auto dealership group in the merger of its dealership with the dealership of another group in the Colorado mountains.
  • Represented a public oil and gas company (NYSE) in its acquisition of an exploration and production business through a reverse triangular merger.°
  • Represented a real estate investment group in restructuring the ownership of various capital and profits interest in several special purpose entities and operating joint ventures, including related management fees and control rights.
  • Represented a multinational Mexican public company (NYSE) in its reorganization and restructuring of approximately $3 billion in cement and aggregates assets located in the U.S.
  • Represented a large, privately held Dutch biotech company in a complex reverse stock split transaction to consolidate ownership of its majority owned U.S. subsidiary.
  • Represented a public semiconductor company (Nasdaq) in connection with the reorganization of its entire capital structure, including the conversion of "toxic preferred stock" to common stock and the retirement of its outstanding debt.°
  • Represented a regional bank (i) in a series of loans for the acquisition and operation of various solar co-generation facilities located in Minnesota, and (ii) a credit facility to fund a business focused on financing medical expenses of tort victims.
  • Represented a natural resources company in negotiating and restructuring a $45,000,000 credit facility for acquisitions and operations.
  • Represented Lapmaster Group Holdings, a private company engaged in the manufacture, marketing, distribution and sale of lapping, grinding and polishing machines, in financing its strategic acquisition of all of the stock of a global German company through a complex structure of senior bank debt, including an enhanced revolving facility, subordinate mezzanine debt (with a related equity stake in the parent company) and seller debt (with a senior position on the German assets of the target), including various pledges and guarantees from certain legacy and newly acquired direct and indirect international subsidiaries (China, India, UK, Singapore, Japan).
  • Represented various lenders and borrowers in connection with establishing revolving credit facilities ranging from $5,000,000 to $100,000,000 for short term consumer loan businesses.
  • Represented a technology company that provides on-site, hybrid and multi-cloud disaster prevention and recovery software in numerous private placements of between $1 million and $10 million of preferred stock and convertible debt and warrants.
  • Represented a biotech company which has developed a proprietary method for delivering vaccines in a fast, efficient and affordable manner in several preferred stock financing rounds of between $3 million and $20 million.
  • Represented a private holding company engaged in the acquisition and operation of midstream oil and gas assets in connection with numerous institutional investments ranging in size from $30 million to $150 million, including related investments in the general partner, as well as several separate private placements of between $3 million and $15 million. 
  • Represented a real estate developer in raising an aggregate of approximately $3.5 million in two separate preferred equity offerings to fund the renovation of a community ice rink and to construct an additional rink in another locations.
  • Represented a private geothermal exploration and development company in connection with several financings and institutional investments, including a $37 million draw down under the principal stockholder’s credit facility, $35 million investment in senior secured convertible notes, $145 million investment in convertible preferred stock, $45 million investment in senior secured promissory notes and warrants and $105 million investment in convertible preferred stock and common stock.
  • Represented a private company engaged in commercializing its proprietary “4D” audio software and related technology in numerous private placements of preferred stock, common stock, convertible debt and warrants ranging in size from approximately $1 million to $5 million. 
  • Represented a public holding company that owns and operates entertainment content (Nasdaq) in connection with its initial preferred stock and bridge loan financings to acquire a controlling interest in the assets of the Elvis Presley Estate and a subsequent credit facility to purchase 19 Entertainment, the owner of the IDOLS brand.
  • Represented various real estate, impact investment and other funds in offering their limited partnership and membership interests to investors as well as multiple starts-up and early stage growth companies in raising capital through private placement transactions.
  • Represented two different sponsors in connection with the formation of two private REIT funds ranging in size from $100,000,000 to $200,000,000 to acquire and operate multifamily apartments throughout the United States.
  • Represented several private real estate funds ranging in size from $10 million to $60 million formed to acquire, flip and sell residential real estate in the Western United States, to develop (horizontally and vertically) commercial and residential projects in the Southeastern United States, to acquire and operate commercial property in the Denver metropolitan area and to purchase and finance mortgage loans.
  • Represented a venture fund formed to invest in socially responsible companies engaged in sustainable business practices.
  • Represented a publicly traded banking institution (NYSE) in connection with significant investments in a Community Reinvestment Act (CRA) compliance fund and in a fund focused on acquiring orphaned, non-core divisions of larger companies. 
  • Represented a medical device company in the licensing, manufacturing and distribution of its patented acoustical percussor used by patients with chronic breathing problems for airway clearance.
  • Represented a personal lubricant business in the outbound licensing of its patented "fertility friendly" vaginal lubricant technology.
  • Represented an auto recycling company in the outbound licensing of its proprietary management software for the vehicle dismantling and salvage industries. 
  • Represented an agricultural R&D company in the outbound licensing of its patented biodegradable machine oil.
  • Represented a global, foreign biotech company in several complex multi-party, multimillion-dollar intellectual property cross-licensing transactions involving patented polymerases for identifying anti-microbial agents for use in preventative medicine and therapeutics.°
  • Represented two biotech businesses in obtaining access to blocking and other mission critical technologies from third parties, including public research universities, as well as the outbound licensing of their patented technologies, which included targeted immunosuppressive therapies and drugs for organ transplantation and polymeric coatings for stints.°
  • Represented a major fitness equipment manufacturer in the inbound licensing of certain mechanical inventions for incorporation into existing patented technologies.°
  • Represented several entrepreneurial construction companies in the outbound licensing of various proprietary railing, wall and steel flooring systems.°
  • Represented two financial services businesses in connection with the development and outbound licensing of their proprietary back office software programs for the securities and collection industries.°
  • Represented several U.S. and foreign businesses in connection with domestic and international manufacturing and distribution of diverse products, including premium orthodontics, polymer coatings, diamond wire saws and diamond wire, biomedical waste disposal equipment, cardiopulmonary devices and supplies, intravenous fluid warmers, plunger lift systems for oil wells, concave surface printers, component wine racks, and plush toys.

° The above representations were handled by Mr. Huber prior to his joining Greenberg Traurig, LLP.

Riconoscimenti e Premi

  • Board Member, Project PAVE, 2009-Present
  • Member, American Bar Association, 1997-Present
  • Member, Colorado Bar Association, 1997-Present
  • Member, Denver Bar Association, 1997-Present
  • Leadership Denver, Class of 2009

Formazione

Formazione
  • Laurea magistrale in Giurisprudenza, University of Colorado Law School, 1997
  • Diploma di maturità, History, University of Colorado at Boulder, 1993
    • Phi Beta Kappa
Abilitazioni
  • Colorado
  • U.S. District Court for the District of Colorado
Lingue